אדמפאס 2.5 מג Izrael - hebrejski - Ministry of Health

אדמפאס 2.5 מג

bayer israel ltd - riociguat - טבליות מצופות פילם - riociguat 2.5 mg - riociguat

אדמפאס 2.5 מג Izrael - hebrejski - Ministry of Health

אדמפאס 2.5 מג

bayer israel ltd - riociguat - טבליות מצופות פילם - riociguat 2.5 mg - riociguat

קסרלטו 15 מג Izrael - hebrejski - Ministry of Health

קסרלטו 15 מג

bayer israel ltd - rivaroxaban micronized - טבליות מצופות פילם - rivaroxaban micronized 15 mg - rivaroxaban - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age?75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

קסרלטו 15 מג Izrael - hebrejski - Ministry of Health

קסרלטו 15 מג

bayer israel ltd - rivaroxaban micronized - טבליות מצופות פילם - rivaroxaban micronized 15 mg - rivaroxaban - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age?75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

קסרלטו 20 מג Izrael - hebrejski - Ministry of Health

קסרלטו 20 מג

bayer israel ltd - rivaroxaban micronized - טבליות מצופות פילם - rivaroxaban micronized 20 mg - rivaroxaban - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age?75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

קסרלטו 20 מג Izrael - hebrejski - Ministry of Health

קסרלטו 20 מג

bayer israel ltd - rivaroxaban micronized - טבליות מצופות פילם - rivaroxaban micronized 20 mg - rivaroxaban - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age?75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

לויטרה 5 מג Izrael - hebrejski - Ministry of Health

לויטרה 5 מג

bayer israel ltd - vardenafil as hydrochloride trihydrate - טבליות מצופות פילם - vardenafil as hydrochloride trihydrate 5 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

לויטרה 10 מג Izrael - hebrejski - Ministry of Health

לויטרה 10 מג

bayer israel ltd - vardenafil as hydrochloride trihydrate - טבליות מצופות פילם - vardenafil as hydrochloride trihydrate 10 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

לויטרה 20 מג Izrael - hebrejski - Ministry of Health

לויטרה 20 מג

bayer israel ltd - vardenafil as hydrochloride trihydrate - טבליות מצופות פילם - vardenafil as hydrochloride trihydrate 20 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

סטיוורגה Izrael - hebrejski - Ministry of Health

סטיוורגה

bayer israel ltd - regorafenib - טבליות מצופות פילם - regorafenib 40 mg - regorafenib - regorafenib - stivarga is indicated for the treatment of patients with metastatic colorectal cancer (crc) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf therapy, and if kras wild-type, an anti-egfr therapy.for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumors (gist) who have been previously treated with imatinib mesylate and sunitinib malate